| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6249505 | Transplantation Proceedings | 2011 | 4 Pages |
Abstract
Sirolimus given alone or in combination with CNIs appears to be an effective primary immunosuppressant regimen for OLT patients. However, in the late postoperative period (>3 months) the drug is associated with a relatively high rate of side effects.
Related Topics
Health Sciences
Medicine and Dentistry
Surgery
Authors
F. Panaro, T. Piardi, F. Gheza, B. Ellero, M. Audet, M. Cag, J. Cinqualbre, P. Wolf,